Overall, through multi-omics studies, we aimed to generate a list of putative non-HIFα targets for VHL, uncover potentially additional functional mechanisms of VHL and illuminate new therapeutic opportunities with VHL-deficient ccRCC. Here, VHL is linked to nonpapillary renal cell carcinoma.